AI technologies are reshaping diagnostics and research across healthcare. At Kaiser Permanente, ambient scribes have gained traction, while attention shifts to AI in denials management and agent use. The University of Texas at Arlington applies AI-driven personalized interventions to boost physical activity in cancer survivors. Intelliseq integrates Genomenon’s Cancer Knowledgebase to enhance somatic variant interpretation. Collaborative efforts between Agenus and Noetik employ large multimodal models to predict cancer immunotherapy biomarkers. These innovations underline AI’s expanding role in precision medicine and operational efficiency.